|
|
Post by dreamboatcruise on May 10, 2018 13:42:52 GMT -5
It would be great if we ended in green today after a clear short attack this morning that fizzled pretty quickly. So I’m on the sidelines cheering for the good guys to win the day. Cmon green! Given that I missed buying the bear attack this morning, I'm hoping they strike once more  |
|
|
|
Post by brotherm1 on May 10, 2018 20:14:55 GMT -5
230K+ shares traded at 4:54 PM. $1.77
|
|
|
|
Post by peppy on May 10, 2018 20:24:02 GMT -5
230K+ shares traded at 4:54 PM. $1.77 yes, I saw that bringing total volume to, 1,671,287 shares. volume stoped after the first 40 minutes and came back in at the end of day. share price should start to pop prior to the ADA. all systems are go. some excitement and buyers taking share price up would be nice. |
|
|
|
Post by peppy on May 11, 2018 13:27:17 GMT -5
|
|
|
|
Post by kite on May 11, 2018 13:43:59 GMT -5
|
|
|
|
Post by xanet on May 11, 2018 14:17:17 GMT -5
We may have to rename this thread "Volume Force" |
|
|
|
Post by peppy on May 11, 2018 14:28:44 GMT -5
well look there. the 1.86, through the 1.86, comes. 2.00.
1,473,885 shares traded real time with 1/2 hour left to go.
|
|
|
|
Post by kite on May 11, 2018 14:33:50 GMT -5
We may have to rename this thread "Volume Force" May the force be with us! |
|
|
|
Post by dreamboatcruise on May 11, 2018 14:49:52 GMT -5
DXCM and MNKD both shining today  |
|
|
|
Post by peppy on May 11, 2018 15:38:25 GMT -5
MNKD Nasdaq real time volume, 1,805,790 shares MNKD Nasdaq summary volume, 2,571,738 shares, MNKD $1.85 +0.08. +4.52% after hours. 8,870 shares. MNKD $1.88. +0.03. +1.62% www.nasdaq.com/symbol/mnkdadded: after hours 75,862 shares. with time left to go. www.nasdaq.com/symbol/mnkd/after-hoursSince we can not fix stupid, can someone figure out why volume seemed to come in coinciding with the pharmaceutical pricing news? |
|
|
|
Post by agedhippie on May 11, 2018 18:46:31 GMT -5
MNKD Nasdaq real time volume, 1,805,790 shares MNKD Nasdaq summary volume, 2,571,738 shares, MNKD $1.85 +0.08. +4.52% after hours. 8,870 shares. MNKD $1.88. +0.03. +1.62% www.nasdaq.com/symbol/mnkdadded: after hours 75,862 shares. with time left to go. www.nasdaq.com/symbol/mnkd/after-hoursSince we can not fix stupid, can someone figure out why volume seemed to come in coinciding with the pharmaceutical pricing news? At a guess - because the PBMs and not the pharmas are going to get hit. |
|
|
|
Post by cjm18 on May 11, 2018 19:01:01 GMT -5
MNKD Nasdaq real time volume, 1,805,790 shares MNKD Nasdaq summary volume, 2,571,738 shares, MNKD $1.85 +0.08. +4.52% after hours. 8,870 shares. MNKD $1.88. +0.03. +1.62% www.nasdaq.com/symbol/mnkdadded: after hours 75,862 shares. with time left to go. www.nasdaq.com/symbol/mnkd/after-hoursSince we can not fix stupid, can someone figure out why volume seemed to come in coinciding with the pharmaceutical pricing news? At a guess - because the PBMs and not the pharmas are going to get hit. [ Express scripts and cvs were up today. |
|
|
|
Post by agedhippie on May 11, 2018 20:42:51 GMT -5
At a guess - because the PBMs and not the pharmas are going to get hit. [ Express scripts and cvs were up today. Well there goes that theory! |
|
|
|
Post by peppy on May 12, 2018 18:06:39 GMT -5
At a guess - because the PBMs and not the pharmas are going to get hit. Express scripts and cvs were up today. On the horizon Some of the most theoretical ideas also have the potential to be the most disruptive. One is to upend the existing rebate system, in which drug companies pay rebates, or discounts, off the list price to insurers and employers. But those rebates are often considered trade secrets, and pharmacy-benefit managers pocket a portion of the rebate for themselves, creating what many have described as perverse incentives that keep drug prices rising. The Trump administration has said it is examining whether it should consider rebates to be a form of illegal kickback, a change that would likely require congressional action. www.nytimes.com/2018/05/11/health/trump-drug-prices.html |
|
|
|
Post by digger on May 13, 2018 6:29:03 GMT -5
Express scripts and cvs were up today. On the horizon Some of the most theoretical ideas also have the potential to be the most disruptive. One is to upend the existing rebate system, in which drug companies pay rebates, or discounts, off the list price to insurers and employers. But those rebates are often considered trade secrets, and pharmacy-benefit managers pocket a portion of the rebate for themselves, creating what many have described as perverse incentives that keep drug prices rising. The Trump administration has said it is examining whether it should consider rebates to be a form of illegal kickback, a change that would likely require congressional action. www.nytimes.com/2018/05/11/health/trump-drug-prices.htmlOn the other hand, there comes the risk of "blowback." Take away the rebates/kickbacks and how much will health insurance rates climb in consequence? My own is averaging about a 10% increase a year. |
|
